Clinical Trial Update: IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment) [Phase 3]

View source ↗

Summary

The Phase 3 IMPACT study evaluating ACtonel for osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Actonel (risedronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED